List of bibliographic references indexed by other
Number of relevant bibliographic references: 33.
[0-20] [
0 - 20][
0 - 33][
20-32][
20-40]
| Ident. | Authors (with country if any) | Title |
|---|
| 000378 (2019) |
Hannah Strobel ; Tim Baisch ; Rahel Fitzel ; Katharina Schilberg [Allemagne] ; Markus D. Siegelin [États-Unis] ; Georg Karpel-Massler [Allemagne] ; Klaus-Michael Debatin ; Mike-Andrew Westhoff | Temozolomide and Other Alkylating Agents in Glioblastoma Therapy |
| 000392 (2019) |
Andy S. Ding ; Denis Routkevitch ; Christina Jackson ; Michael Lim | Targeting Myeloid Cells in Combination Treatments for Glioma and Other Tumors |
| 000444 (2019) |
Gulsen Ozen [États-Unis] ; Sofia Pedro [États-Unis] ; Rebecca Schumacher [États-Unis] ; Teresa A. Simon [États-Unis] ; Kaleb Michaud [États-Unis] | Safety of abatacept compared with other biologic and conventional synthetic disease-modifying antirheumatic drugs in patients with rheumatoid arthritis: data from an observational study |
| 000483 (2019) |
Xiangyi Kong [République populaire de Chine] ; Jie Zhai [République populaire de Chine] ; Chengrui Yan [République populaire de Chine] ; Yan Song [République populaire de Chine] ; Jing Wang [République populaire de Chine] ; Xiaofeng Bai [République populaire de Chine] ; James A. L. Brown [Irlande (pays)] ; Yi Fang [République populaire de Chine] | Recent Advances in Understanding FOXN3 in Breast Cancer, and Other Malignancies |
| 000651 (2019) |
Alejandro M. S. Mayer ; Aimee J. Guerrero ; Abimael D. Rodríguez ; Orazio Taglialatela-Scafati ; Fumiaki Nakamura ; Nobuhiro Fusetani | Marine Pharmacology in 2014–2015: Marine Compounds with Antibacterial, Antidiabetic, Antifungal, Anti-Inflammatory, Antiprotozoal, Antituberculosis, Antiviral, and Anthelmintic Activities; Affecting the Immune and Nervous Systems, and Other Miscellaneous Mechanisms of Action |
| 000745 (2019) |
Nagla Fawzy Abdel Karim [États-Unis] ; Rammey Hassan [États-Unis] ; Nabeela Iffat Siddiqi [États-Unis] ; Ihab Eldessouki [États-Unis] ; Ola Gaber [États-Unis] ; Mohamed Rahouma [Égypte] ; Mohamed Kamel [Égypte] ; Mhender Yellu [États-Unis] ; Shuchi Gulati [États-Unis] ; Changchun Xie [États-Unis] ; Mohamed Magdy [Égypte] ; Jane Pruemer [États-Unis] | Impact of tricyclic antidepressants, selective serotonin reuptake inhibitors, and other antidepressants on overall survival of patients with advanced lung cancer from 2004 to 2014: University of Cincinnati experience |
| 000A01 (2019) |
Anjali Patwardhan [États-Unis] ; Charles H. Spencer [États-Unis] | Biologics in refractory myositis: experience in juvenile vs. adult myositis; part II: emerging biologic and other therapies on the horizon |
| 000A92 (2019) |
Anjali Patwardhan [États-Unis] ; Charles H. Spencer [États-Unis] | An unprecedented COPA gene mutation in two patients in the same family: comparative clinical analysis of newly reported patients with other known COPA gene mutations |
| 000D45 (2016-01-13) |
Mathieu Bourdenx [France] ; Jonathan Daniel [France] ; Emilie Genin [France] ; Federico N. Soria [France] ; Mireille Blanchard-Desce [France] ; Erwan Bezard [France] ; Benjamin Dehay [France] | Nanoparticles restore lysosomal acidification defects: Implication for Parkinson and other lysosomal-related diseases. |
| 000F75 (2015) |
José Pardos-Gea [Espagne] ; Gustavo Avegliano [Espagne] ; Arturo Evangelista [Espagne] ; Miguel Vilardell [Espagne] ; José Ordi-Ros [Espagne] | Cardiac manifestations other than valvulopathy in antiphospholipid syndrome: long‐time echocardiography follow‐up study |
| 001188 (2013) |
Fariz Yahya [Malaisie] ; Raja Jasmin [Malaisie] ; Chin Teck Ng [Malaisie] ; Tien Eang Cheah [Malaisie] ; Sargunan Sockalingam [Malaisie] | Open label randomized controlled trial assessing the efficacy of mycophenolate sodium against other conventional immunosuppressive agents in active systemic lupus erythematosus patients without renal involvement |
| 001367 (2012) |
A. Klein [Allemagne] ; B. Coras [Allemagne] ; M. Landthaler [Allemagne] ; P. Babilas [Allemagne] | Off‐label use of fumarate therapy for granulomatous and inflammatory skin diseases other than psoriasis vulgaris: a retrospective study |
| 001387 (2012) |
Richard K. Haynes [République populaire de Chine, Hong Kong, Italie] ; Kwan-Wing Cheu [République populaire de Chine] ; Ho-Wai Chan [République populaire de Chine] ; Ho-Ning Wong [République populaire de Chine] ; Ka-Yan Li [République populaire de Chine] ; Maggie Mei-Ki Tang [République populaire de Chine] ; Min-Jiao Chen [République populaire de Chine] ; Zu-Feng Guo [République populaire de Chine] ; Zhi-Hong Guo [République populaire de Chine] ; Kumar Sinniah [États-Unis] ; Amanda B. Witte [États-Unis] ; Paolo Coghi [Italie] ; Diego Monti [Italie] | Interactions between Artemisinins and other Antimalarial Drugs in Relation to the Cofactor Model—A Unifying Proposal for Drug Action |
| 001517 (2011) |
C. Domingo [Espagne, Canada] ; A. Moreno [Espagne] ; R. Mirapeix [Espagne] | Rationale for the use of immunomodulatory therapies in the Global Initiative for Asthma (GINA) step V asthma other than oral glucocorticosteroids |
| 001B51 (2007) |
Tiina Lev Lampi [Finlande] ; Markku Korpela [Finlande] ; Katriina Vuolteenaho [Finlande] ; Eeva Moilanen [Finlande] | Etanercept and adalimumab treatment in patients with rheumatoid arthritis and spondyloarthropathies in clinical practice: adverse events and other reasons leading to discontinuation of the treatment |
| 001C69 (2006) |
C A Lee [Royaume-Uni] ; D. Mistry [Royaume-Uni] ; R. Sharma [Royaume-Uni] ; A P Coatesworth [Royaume-Uni] | Rhinological, laryngological, oropharyngeal and other head and neck side effects of drugs |
| 001D43 (2006) |
A. Parke [États-Unis] | Drug exposure, pregnancy outcome and fetal and childhood development occurring in the offspring of mothers with systemic lupus erythematosus and other chronic autoimmune diseases |
| 001D70 (2006) |
| BONE DISEASES OTHER THAN OSTEOPOROSIS |
| 001D72 (2006) |
Eric Beitz [Allemagne] | Aquaporin Water and Solute Channels from Malaria Parasites and Other Pathogenic Protozoa |
| 002178 (2002) |
S. Rahlfs [États-Unis] ; R. H. Schirmer [États-Unis] ; K. Becker [États-Unis] | The thioredoxin system of Plasmodium falciparum and other parasites |
| 002547 (2000) |
Chantal Etiévant ; Anna Kruczynski ; Jean-Marc Barret ; Dominique Perrin ; Benoît Van Hille ; Yves Guminski ; Bridget T. Hill | F 11782, a dual inhibitor of topoisomerases I and II with an original mechanism of action in vitro, and markedly superior in vivo antitumour activity, relative to three other dual topoisomerase inhibitors, intoplicin, aclarubicin and TAS-103 |
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/ChloroquineV1/Data/Main/Exploration
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/Title.i -k "other"
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/Title.i \
-Sk "other" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Sante
|area= ChloroquineV1
|flux= Main
|étape= Exploration
|type= indexItem
|index= Title.i
|clé= other
}}
| This area was generated with Dilib version V0.6.33.
Data generation: Wed Mar 25 22:43:59 2020. Site generation: Sun Jan 31 12:44:45 2021 |  |
